Microbot Medical Stock (NASDAQ: MBOT) stock price, news, charts, stock research, profile.
Open | $0.870 |
Close | $0.880 |
Volume / Avg. | 31.899K / 101.117K |
Day Range | 0.861 - 0.889 |
52 Wk Range | 0.860 - 4.370 |
Market Cap | $12.541M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 31 |
Short Interest | 1.36% |
Days to Cover | 2.22 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Microbot Medical (NASDAQ: MBOT) through any online brokerage.
Other companies in Microbot Medical’s space includes: Predictive Oncology (NASDAQ:POAI), Nexalin Technology (NASDAQ:NXL), Venus Concept (NASDAQ:VERO), Talis Biomedical (NASDAQ:TLIS) and QT Imaging Holdings (NASDAQ:QTI).
The latest price target for Microbot Medical (NASDAQ: MBOT) was reported by HC Wainwright & Co. on Tuesday, April 16, 2024. The analyst firm set a price target for 7.00 expecting MBOT to rise to within 12 months (a possible 703.67% upside). 5 analyst firms have reported ratings in the last year.
The stock price for Microbot Medical (NASDAQ: MBOT) is $0.871 last updated April 26, 2024 at 5:42 PM EDT.
There are no upcoming dividends for Microbot Medical.
Microbot Medical’s Q1 earnings are confirmed for Wednesday, May 15, 2024.
There is no upcoming split for Microbot Medical.
Microbot Medical is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.